Life Sciences, Biotech, Stem Cells
Pfizer Starts Stem Cell R&D Unit
Ryan McBride 11/14/08
Drug giant Pfizer (NYSE:PFE) has announced the launch of Pfizer Regenerative Medicine, an independent research unit focused on discovering stem cell treatments for multiple diseases. New York-based Pfizer says the research unit will be co-located in Cambridge, U.K., and at its existing R&D operation— Research Technology Centre—in Cambridge, MA.
Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.
